SCHAFER CULLEN CAPITAL MANAGEMENT INC - Sanofi ownership

Sanofi's ticker is and the CUSIP is F5548N101. A total of 3 filers reported holding Sanofi in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHAFER CULLEN CAPITAL MANAGEMENT INC ownership history of Sanofi
ValueSharesWeighting
Q4 2020$626,000
-9.5%
6,515
-5.9%
0.01%
-18.2%
Q3 2020$692,000
-15.3%
6,920
-13.8%
0.01%
-15.4%
Q2 2020$817,000
+21.0%
8,025
+5.0%
0.01%
+18.2%
Q1 2020$675,000
-11.6%
7,640
+0.5%
0.01%
+22.2%
Q4 2019$764,000
+46.4%
7,603
+35.0%
0.01%
+50.0%
Q3 2019$522,000
-8.4%
5,633
-18.1%
0.01%
-14.3%
Q2 2019$570,000
+9.8%
6,882
+17.2%
0.01%
-12.5%
Q1 2019$519,000
-33.5%
5,872
-34.7%
0.01%
-33.3%
Q4 2018$780,000
-11.9%
8,997
-9.6%
0.01%
+9.1%
Q3 2018$885,000
+9.9%
9,957
-0.8%
0.01%
+10.0%
Q2 2018$805,000
-6.3%
10,037
-6.1%
0.01%0.0%
Q1 2018$859,000
-24.0%
10,692
-18.4%
0.01%
-23.1%
Q4 2017$1,131,000
-14.6%
13,107
-1.8%
0.01%
-18.8%
Q3 2017$1,325,000
+1.5%
13,347
-2.2%
0.02%0.0%
Q2 2017$1,305,000
+47.0%
13,646
+38.7%
0.02%
+45.5%
Q1 2017$888,000
-12.8%
9,835
-21.7%
0.01%
-21.4%
Q4 2016$1,018,000
-17.4%
12,562
-22.5%
0.01%
-6.7%
Q3 2016$1,232,000
-18.2%
16,213
-10.5%
0.02%
-16.7%
Q2 2016$1,506,000
+0.3%
18,123
-2.5%
0.02%0.0%
Q1 2016$1,502,000
+6.5%
18,596
+12.6%
0.02%
+5.9%
Q4 2015$1,410,000
-22.1%
16,516
-13.5%
0.02%
-19.0%
Q3 2015$1,811,000
-2.6%
19,096
+1.0%
0.02%
+10.5%
Q2 2015$1,860,000
+3.0%
18,908
+3.4%
0.02%
+5.6%
Q1 2015$1,806,000
+13.4%
18,289
+5.1%
0.02%
-10.0%
Q4 2014$1,593,000
-45.1%
17,404
-32.1%
0.02%
-28.6%
Q3 2014$2,901,000
+5.0%
25,642
-1.4%
0.03%
+12.0%
Q2 2014$2,763,000
-1.2%
26,017
-3.0%
0.02%
-7.4%
Q1 2014$2,797,000
-5.9%
26,817
-4.1%
0.03%
-6.9%
Q4 2013$2,971,000
-22.3%
27,957
-25.8%
0.03%
-31.0%
Q3 2013$3,826,000
-19.2%
37,701
-17.6%
0.04%
-26.3%
Q2 2013$4,733,00045,7360.06%
Other shareholders
Sanofi shareholders Q3 2017
NameSharesValueWeighting ↓
Cullen Capital Management, LLC 48,961$4,838,0000.05%
CAPTRUST FINANCIAL ADVISORS 220$22,0000.00%
View complete list of Sanofi shareholders